Analysts think CLDX stock price could increase by 196%
Jun 05, 2025, 11:25 AM
2.11%
What does CLDX do
Celldex Therapeutics, based in Hampton, New Jersey, develops novel therapeutics targeting mast cell-mediated diseases and employs 160 staff. Their pipeline includes Barzolvolimab and the bispecific antibody CDX-585 for inflammatory diseases and oncology.
14 analysts think CLDX stock price will increase by 195.80%. The current median analyst target is $58.14 compared to a current stock price of $19.66. The lowest analysts target is $31.31 and the highest analyst target is $94.50.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.